1. Immunology and Inflammation
  2. Structural Biology and Molecular Biophysics

FcγRIIB-I232T polymorphic change allosterically suppresses ligand binding

  1. Wei Hu
  2. Yong Zhang
  3. Xiaolin Sun
  4. Tongtong Zhang
  5. Liling Xu
  6. Hengyi Xie
  7. Zhanguo Li
  8. Wanli Liu  Is a corresponding author
  9. Jizhong Lou  Is a corresponding author
  10. Wei Chen  Is a corresponding author
  1. Zhejiang University School of Medicine, China
  2. Institute of Biophysics, Chinese Academy of Sciences, China
  3. Peking University People's Hospital, China
  4. Tsinghua University, China
https://doi.org/10.7554/eLife.46689
Share this article
Cite this article
  1. Wei Hu
  2. Yong Zhang
  3. Xiaolin Sun
  4. Tongtong Zhang
  5. Liling Xu
  6. Hengyi Xie
  7. Zhanguo Li
  8. Wanli Liu
  9. Jizhong Lou
  10. Wei Chen
(2019)
FcγRIIB-I232T polymorphic change allosterically suppresses ligand binding
eLife 8:e46689.
https://doi.org/10.7554/eLife.46689
  2. Download BibTeX
  3. Download .RIS

Abstract

FcγRIIB binding to its ligand suppresses immune cell activation. A single-nucleotide polymorphic (SNP) change, I232T, in the transmembrane (TM) domain of FcγRIIB loses its suppressive function, which is clinically associated with systemic lupus erythematosus (SLE). Previously, we reported that I232T tilted FcγRIIB's TM domain. In this study, combining with molecular dynamics simulations and single-cell FRET assay, we further reveal that such tilting by I232T unexpectedly bends the FcγRIIB's ectodomain towards plasma membrane to allosterically impede FcγRIIB's ligand association. I232T substitution reduces in-situ two-dimensional binding affinities and association rates of FcγRIIB to interact with its ligands, IgG1, IgG2 and IgG3 by three to four folds. This allosteric regulation by a SNP provides an intrinsic molecular mechanism for the functional loss of FcγRIIB-I232T in SLE patients.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files.

Article and author information

Author details

  1. Wei Hu

    Department of Neurobiology, Institute of Neuroscience, Zhejiang University School of Medicine, Zhejiang, China
    Competing interests
    The authors declare that no competing interests exist.

  2. Yong Zhang

    CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.

  3. Xiaolin Sun

    Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.

  4. Tongtong Zhang

    Department of Neurobiology, Institute of Neuroscience, Zhejiang University School of Medicine, Zhejiang, China
    Competing interests
    The authors declare that no competing interests exist.

  5. Liling Xu

    Institute for Immunology, Tsinghua University, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.

  6. Hengyi Xie

    Institute for Immunology, Tsinghua University, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.

  7. Zhanguo Li

    Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.

  8. Wanli Liu

    School of Life Sciences, Tsinghua University, Beijing, China
    For correspondence
    liulab@tsinghua.edu.cn
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0395-2800

  9. Jizhong Lou

    CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China
    For correspondence
    jlou@ibp.ac.cn
    Competing interests
    The authors declare that no competing interests exist.

  10. Wei Chen

    Department of Neurobiology, Institute of Neuroscience, Zhejiang University School of Medicine, Zhejiang, China
    For correspondence
    jackweichen@zju.edu.cn
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5366-7253

Funding

Natural Basic Research Program of China (2015CB910800)

  • Wei Chen

Natural Science Foundation of China (31470900)

  • Wei Chen

Natural Science Foundation of China (31522021)

  • Wei Chen

Natural Science Foundation of China (11672317)

  • Jizhong Lou

Natural Science Foundation of China (11772348)

  • Yong Zhang

Fundamental Research Founds for the Central Universities (2015XZZX004-32)

  • Wei Chen

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: The ethics committee of Peking University People's Hospital approved this study and informed consents were obtained from each patient and healthy volunteer. All the human cell associated experimental guidelines were approved by the Medical Ethics Committee of Peking University People's Hospital (approval no. 2014PHB116-01) and by the Medical Ethics Committee of Tsinghua University (approval no. 20180029).

Copyright

© 2019, Hu et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,639
    views
  • 293
    downloads
  • 20
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Wei Hu
  2. Yong Zhang
  3. Xiaolin Sun
  4. Tongtong Zhang
  5. Liling Xu
  6. Hengyi Xie
  7. Zhanguo Li
  8. Wanli Liu
  9. Jizhong Lou
  10. Wei Chen
(2019)
FcγRIIB-I232T polymorphic change allosterically suppresses ligand binding
eLife 8:e46689.
https://doi.org/10.7554/eLife.46689

Share this article

https://doi.org/10.7554/eLife.46689

Categories and tags

Research organism

Further reading

    1. Immunology and Inflammation

    RAG suppresses group 2 innate lymphoid cells

    Aaron M Ver Heul, Madison Mack ... Brian S Kim
    Research Article

    Antigen specificity is the central trait distinguishing adaptive from innate immune function. Assembly of antigen-specific T cell and B cell receptors occurs through V(D)J recombination mediated by the Recombinase Activating Gene endonucleases RAG1 and RAG2 (collectively called RAG). In the absence of RAG, mature T and B cells do not develop and thus RAG is critically associated with adaptive immune function. In addition to adaptive T helper 2 (Th2) cells, group 2 innate lymphoid cells (ILC2s) contribute to type 2 immune responses by producing cytokines like Interleukin-5 (IL-5) and IL-13. Although it has been reported that RAG expression modulates the function of innate natural killer (NK) cells, whether other innate immune cells such as ILC2s are affected by RAG remains unclear. We find that in RAG-deficient mice, ILC2 populations expand and produce increased IL-5 and IL-13 at steady state and contribute to increased inflammation in atopic dermatitis (AD)-like disease. Furthermore, we show that RAG modulates ILC2 function in a cell-intrinsic manner independent of the absence or presence of adaptive T and B lymphocytes. Lastly, employing multiomic single cell analyses of RAG1 lineage-traced cells, we identify key transcriptional and epigenomic ILC2 functional programs that are suppressed by a history of RAG expression. Collectively, our data reveal a novel role for RAG in modulating innate type 2 immunity through suppression of ILC2s.

    1. Immunology and Inflammation

    Bacterial Clearance: With a little help from T cells

    Troy Burtchett, Neal Hammer
    Insight

    Specific host factors, such as immune cell activity, sex hormones and microbiota composition, influence the ability of Staphylococcus aureus bacteria to colonize the gut of mice.

    1. Immunology and Inflammation
    2. Neuroscience

    Microglia aging in the hippocampus advances through intermediate states that drive activation and cognitive decline

    Jeremy M Shea, Saul A Villeda
    Research Article

    During aging, microglia – the resident macrophages of the brain – exhibit altered phenotypes and contribute to age-related neuroinflammation. While numerous hallmarks of age-related microglia have been elucidated, the progression from homeostasis to dysfunction during the aging process remains unresolved. To bridge this gap in knowledge, we undertook complementary cellular and molecular analyses of microglia in the mouse hippocampus across the adult lifespan and in the experimental aging model of heterochronic parabiosis. Single-cell RNA-Seq and pseudotime analysis revealed age-related transcriptional heterogeneity in hippocampal microglia and identified intermediate states of microglial aging that also emerge following heterochronic parabiosis. We tested the functionality of intermediate stress response states via TGFβ1 and translational states using pharmacological approaches in vitro to reveal their modulation of the progression to an activated state. Furthermore, we utilized single-cell RNA-Seq in conjunction with in vivo adult microglia-specific Tgfb1 conditional genetic knockout mouse models to demonstrate that microglia advancement through intermediate aging states drives transcriptional inflammatory activation and hippocampal-dependent cognitive decline.